About Mazence
Mazence is a company based in Suwon (South Korea) founded in 2008 was acquired by KT&G in December 2011. Mazence operates in a competitive market with competitors including Adocia, BioAge Labs, Carmot, Fractyl and Altimmune, among others.
- Headquarter Suwon, South Korea
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Mazence
Investors in Mazence
Mazence has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include KT&G.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tobacco products, ginseng, pharmaceuticals, and health goods are manufactured.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mazence
Financial Statements - Mazence
Mazence Comparisons
Competitors of Mazence
Mazence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, BioAge Labs, Carmot, Fractyl and Altimmune, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Endoscopic procedures for type-2 diabetes treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases and solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Developing and marketing drugs for the treatment of obesity.
|
Latest news on Mazence
Frequently Asked Questions about Mazence
Mazence was founded in 2008.
Mazence is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
Mazence was established in 2008 in Suwon-si, South Korea, as a pharmaceutical entity. Small molecule combination formulations were created by the company to target metabolic conditions, including obesity, diabetes, and metabolic syndrome, along with neurodegenerative and mitochondrial dysfunction diseases. Operations centered on drug development in these therapeutic areas. The company was acquired by KTG on December 27, 2011, for USD 25.95 million.
Mazence's top competitors include Adocia, BioAge Labs and Fractyl.
Mazence has 1 investor. Key investors include KT&G.